Cathepsin D improves the prediction of undetected diabetes in patients with myocardial infarction

Background: Newer therapeutic agents for type 2 diabetes mellitus can improve cardiovascular outcomes, but diabetes remains underdiagnosed in patients with myocardial infarction (MI). We sought to identify proteomic markers of undetected dysglycaemia (impaired fasting glucose, impaired glucose toler...

Descripción completa

Detalles Bibliográficos
Autores principales: Velders, Matthijs A., Calais, Fredrik, Dahle, Nina, Fall, Tove, Hagström, Emil, Leppert, Jerzy, Nowak, Christoph, Tenerz, Åke, Ärnlöv, Johan, Hedberg, Pär
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2019
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7182365/
https://www.ncbi.nlm.nih.gov/pubmed/31429631
http://dx.doi.org/10.1080/03009734.2019.1650141

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7182365/
https://www.ncbi.nlm.nih.gov/pubmed/31429631
http://dx.doi.org/10.1080/03009734.2019.1650141

Ejemplares similares